HomeCHRO • NYSEAMERICAN
add
Chromocell Therapeutics Corp
Previous close
$1.50
Day range
$1.47 - $1.78
Year range
$1.21 - $6.00
Market cap
9.40M USD
Avg Volume
30.65K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.30M | 57.87% |
Net income | -4.04M | -221.22% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 96.39K | 75.02% |
Total assets | 96.39K | 75.02% |
Total liabilities | 6.54M | 73.89% |
Total equity | -6.44M | — |
Shares outstanding | 5.88M | — |
Price to book | -0.91 | — |
Return on assets | -16,273.47% | — |
Return on capital | 196.27% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.04M | -221.22% |
Cash from operations | -356.81K | 46.48% |
Cash from investing | — | — |
Cash from financing | 430.41K | -21.52% |
Net change in cash | 73.60K | 162.29% |
Free cash flow | -1.07M | -447.39% |
About
Founded
2002
Website
Employees
4